The serum tumor markers carbohydrate antigen (CA) 19-9 and 125 (CA 125) and carcinoembryonic antigen (CEA) are used in routine practice to help CCA diagnosis and mostly to monitor disease progression once diagnosis has been achieved [13]. Here, CEACAM5 is linked to cholangiocarcinoma.